Myelodysplastic Syndrome
Showing NaN - NaN of 71
Leukemia, Myelodysplastic Syndrome Trial in New York (WT1-sensitized T cells)
Completed
- Leukemia
- Myelodysplastic Syndrome
- WT1-sensitized T cells
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 1, 2021
Myelodysplastic Syndrome, MDS Trial in Canada, United States (ASTX727 Dose Escalation, ASTX727 Dose Confirmation, ASTX727
Completed
- Myelodysplastic Syndrome
- MDS
- ASTX727 Dose Escalation
- +2 more
-
Phoenix, Arizona
- +16 more
Dec 1, 2020
Women Who Survived Cancer orRelated Illness Following Total Body
Completed
- Leukemia
- +3 more
- Questionnaires, Laboratory tests, Abdominal MRI
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 3, 2020
Myelodysplastic Syndrome Trial in New York (rigosertib)
Withdrawn
- Myelodysplastic Syndrome
-
New York, New YorkColumbia University Medical Center
Jun 29, 2020
Testing in Patients Undergoing Hematopoietic Cell
Completed
- Acute Myeloid Leukemia
- +5 more
- Symptom-limited cardiopulmonary exercise test (CPET)
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Apr 15, 2020
Myelodysplastic Syndrome Trial in New York (lenalidomide, cyclosporine A)
Terminated
- Myelodysplastic Syndrome
- lenalidomide
- cyclosporine A
-
New York, New YorkWeill Cornell Medical College
Nov 1, 2019
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in Baltimore, New York
Completed
- Acute Myeloid Leukemia
- +7 more
-
Baltimore, Maryland
- +2 more
Oct 17, 2019
Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma Trial in New York (Cyclophosphamide)
Terminated
- Leukemia
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 22, 2019
Myelodysplastic Syndrome Trial in Worldwide (MEDI4736 Evaluate MEDI4736 in MDS, VIDAZA, tremelimumab)
Completed
- Myelodysplastic Syndrome
- MEDI4736 Evaluate MEDI4736 in MDS
- +2 more
-
Scottsdale, Arizona
- +20 more
May 9, 2019
Myelodysplastic Syndrome Trial in New York (Vosaroxin)
Completed
- Myelodysplastic Syndrome
-
New York, New YorkWeill Cornell Medical College
Jan 24, 2019
Myelodysplastic Syndrome Trial in United States (vadastuximab talirine, Azacitidine, Placebo (for 33A))
Terminated
- Myelodysplastic Syndrome
- vadastuximab talirine
- +2 more
-
Gilbert, Arizona
- +33 more
Jan 23, 2019
Acute Leukemia, Chronic Leukemia, Myelodysplastic Syndrome Trial in New York (radiation, drug, biological, procedure, other)
Terminated
- Acute Leukemia
- +3 more
- total-body irradiation (TBI)
- +7 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 12, 2018
Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in New York (device, drug, procedure)
Terminated
- Acute Myelogenous Leukemia
- +4 more
- CliniMACS® CD34 Reagent System
- +5 more
-
New York, New YorkWeill Cornell Medical College
Jun 12, 2018
Aplastic Anemia, Leukemia, Myelodysplastic Syndrome Trial in United States (Busulfan, fludarabine, & cyclophosphamide with
Completed
- Aplastic Anemia
- +2 more
- Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine.
- CliniMACS device
-
Boston, Massachusetts
- +5 more
Jun 14, 2018
Myelodysplastic Syndrome Trial in New York (Tosedostat)
Completed
- Myelodysplastic Syndrome
-
New York, New YorkWeill Cornell Medical College
Jun 7, 2018
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (micafungin, posaconazole)
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Apr 4, 2018
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome
Completed
- Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
- +5 more
- Ipilimumab
- Laboratory Biomarker Analysis
-
New Haven, Connecticut
- +8 more
Mar 20, 2018
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (CPX-351)
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
-
New York, New YorkWeill Cornell Medical College
Jan 12, 2018